SEC Tracker
Get the app

Corcept Therapeutics CORT

Corcept Therapeutics reports beneficial ownership by Gunn

Justin Frederick Gunn, new insider at CORT

Form
3
Filed
Importance
Routine
  1. Gunn Justin Frederick, President
  2. 12,191 common shares owned directly
  3. 25,000 stock options exercisable by 2034
  4. Multiple stock options with vesting schedules

Written from the Form 3 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Corcept Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Repligen RGEN public float $6.0B, Jun 30, 2025
  2. Jazz Pharmaceuticals JAZZ public float $6.3B, Jun 30, 2025
  3. Madrigal Pharmaceuticals MDGL public float $5.6B, Jun 30, 2025
  4. Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025
  5. Revolution Medicines RVMD public float $6.7B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.